Kiniksa Pharmaceuticals International, Plc
Clinical trials sponsored by Kiniksa Pharmaceuticals International, Plc, explained in plain language.
-
New drug trial aims to tame painful, recurring heart inflammation
Disease control Recruiting nowThis study is testing a new drug called KPL-387 to see if it can effectively treat and prevent the return of recurrent pericarditis, a painful inflammation of the heart's lining. It will involve about 165 adults who continue to have flare-ups despite standard treatments. The rese…
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New drug aims to tame recurring heart inflammation
Disease control Recruiting nowThis study is testing a medication called KPL-387 for people with recurrent pericarditis, a painful inflammation around the heart. The main goal is to see if patients can safely switch from their current treatments to KPL-387 alone and stay free of flare-ups. Researchers will fol…
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC